scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.RADONC.2008.07.013 |
P698 | PubMed publication ID | 18722684 |
P2093 | author name string | You Lu | |
Wenhao Guo | |||
Bingwen Zou | |||
Yongshun Chen | |||
P2860 | cites work | 100 years of lung cancer | Q34000402 |
P433 | issue | 3 | |
P304 | page(s) | 351-358 | |
P577 | publication date | 2008-08-21 | |
P1433 | published in | Radiotherapy and Oncology | Q14251029 |
P1476 | title | Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy | |
P478 | volume | 88 |
Q48256303 | A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making |
Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
Q61804642 | Approaches to stereotactic body radiation therapy for large (≥5 centimeter) non-small cell lung cancer |
Q40608540 | Assessing the Need for Adjuvant Chemotherapy After Stereotactic Body Radiation Therapy in Early-stage Non-small Cell Lung Carcinoma |
Q31152462 | Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT |
Q28083924 | Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? |
Q38663392 | Clinical Outcomes of 130 Patients with Primary and Secondary Lung Tumors treated with Cyberknife Robotic Stereotactic Body Radiotherapy |
Q34202715 | Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size |
Q48316437 | Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma |
Q57175083 | Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham's (UK) Experience |
Q99582898 | Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer |
Q40542033 | Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors |
Q91830232 | Prognostic Role Of Computed Tomography Textural Features In Early-Stage Non-Small Cell Lung Cancer Patients Receiving Stereotactic Body Radiotherapy |
Q26823043 | Radiation dose effect in locally advanced non-small cell lung cancer |
Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
Q34304095 | Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects |
Q37025540 | Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer. |
Search more.